GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death

Findings suggest a potential role in both prevention and treatment of various substance use disorders, say researchers

2026-03-05

(Press-News.org) Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including alcohol, cannabis, cocaine, nicotine, and opioids, finds a large US study published by The BMJ today.

GLP-1 receptor agonists were also associated with reduced risks of adverse outcomes such as overdoses and drug-related emergency department visits and deaths in people with pre-existing substance use disorders, the results show.

Some studies suggest that GLP-1 receptor agonists act on the brain’s reward pathway, potentially explaining why a drug developed for diabetes and obesity might reduce the risk of alcohol, tobacco and cannabis use disorders. However, large studies confirming their role in preventing or improving outcomes for established substance use disorders are lacking.

To address this, researchers based in Saint Louis, Missouri used US Department of Veterans Affairs data to investigate if starting GLP-1 receptor agonists is associated with a reduced risk of various substance use disorders (SUDs) in people without a history of SUDs.

They also examined if GLP-1 receptor agonists reduced adverse SUD-related clinical outcomes, such as drug-related emergency department visits and death, overdose, and suicidal behaviour, in those with pre-existing SUDs.

Their findings are based on 606,434 US veterans with type 2 diabetes who were monitored for up to 3 years. In both sets of analyses, GLP-1 receptor agonists were compared with another group of diabetes drugs known as sodium-glucose cotransporter-2 (SGLT-2) inhibitors.

In veterans with no history of SUDs, starting a GLP-1 receptor agonist was associated with an overall 14% reduced risk of SUDs and a reduced risk of disorders specifically related to use of alcohol (18%), cannabis (14%), cocaine (20%), nicotine (20%) and opioids (25%) compared with an SGLT2 inhibitor, translating to roughly 1-6 fewer cases per 1000 people over three years.

Among veterans with a pre-existing SUD, starting a GLP-1 receptor agonist was associated with fewer SUD related emergency department visits (31%), hospital admissions (26%), deaths (50%), overdose (39%), and suicidal ideation or attempt (25%), translating to about 1-10 fewer events per 1000 people over three years.

The authors acknowledge several limitations. For example, the study was conducted within the Veterans Affairs healthcare system, which includes predominantly older men, though subgroup analyses showed consistent results in women, and they can’t rule out the possibility that other unmeasured factors, such as socioeconomic status or lifestyle, may have affected their results.

However, by using a rigorous emulated target trial design they reduced much of the bias common to observational studies, and results were consistent after further analyses, suggesting that they are robust.

As such, they conclude: “These observational data suggest a potential role for GLP-1 receptor agonists in both the prevention and the treatment of various SUDs, warranting further evaluation.”

This study strengthens the case that GLP-1 receptor agonists may influence substance related outcomes in real world practice, says Fares Qeadan at Loyola University Chicago, in a linked editorial.

While caution is still warranted and evidence based treatments remain the preferred treatments, these results suggest that when GLP-1 receptor agonists are clinically indicated for cardiometabolic reasons, “potential benefits for substance related outcomes may be an added consideration in shared decision making,” he writes.

The challenge is to translate this signal into trials and equitable care pathways while continuing to scale proven treatments for SUDs, he concludes.

END

ELSE PRESS RELEASES FROM THIS DATE:

Councils face industry legal threats for campaigns warning against wood burning stoves

2026-03-05

As the UK government considers adding health warnings to new wood burning stoves, as part of a public consultation on solid fuel burning, councils in England are being threatened with legal action for running public health campaigns warning against their use, reveals an investigation published by The BMJ today. Freedom of Information requests show that just under a third of the 50 councils in England with the highest concentration of wood burning stoves had been threatened with legal action or lobbied by the Stove Industry Association (SIA). Other local authorities have received leaflets from the main stove ...

GLP-1 medications get at the heart of addiction: study

2026-03-05

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major addictive substances studied, suggesting these drugs target a common biological pathway underlying addiction. From their beginnings as a treatment for type 2 diabetes, GLP-1 receptor agonists such as semaglutide and tirzepatide have seen an explosion in use, most popularly for weight loss. Patients have reported decreased interest in alcohol and nicotine when taking GLP-1s, and observational studies have shown an association between ...

Global trauma study highlights shared learning as interest in whole blood resurges

2026-03-05

A new international study published in The Lancet eClinicalMedicine has mapped global blood transfusion practices for life-threatening abdominal injuries, highlighting significant variation in care worldwide and opportunities for health systems to learn from one another. The research, led by the University of Cambridge as part of the GOAL-Trauma study, analysed data from 1,768 patients treated in 187 hospitals across 51 countries. It represents the first multicentre international study to report on blood transfusion strategies for patients undergoing emergency abdominal surgery following trauma (trauma laparotomy). Uncontrolled bleeding is the leading cause of death following ...

Almost a third of Gen Z men agree a wife should obey her husband

2026-03-05

31% of Gen Z men agree that a wife should always obey her husband and one third (33%) say a husband should have the final word on important decisions, according to a new global study of 23,000 people. Gen Z men (born between 1997 and 2012) were twice as likely as Baby Boomer men (born between 1946 and 1964) to have traditional views on decision-making within a marriage, with just 13% and 17% of Baby Boomer men agreeing with those statements respectively. By contrast, far fewer Gen Z women agreed that a wife should always obey her husband (18%) and ...

Trapping light on thermal photodetectors shatters speed records

2026-03-04

Electrical engineers at Duke University have demonstrated the fastest pyroelectric photodetector to date that works by absorbing heat generated by incoming light. Capable of capturing light from the entire electromagnetic spectrum, the ultrathin device requires no external power, operates at room temperature and can be readily integrated into on-chip applications. The advance could form the basis of a new class of multispectral cameras capable of impacting a wide range of fields such as skin cancer detection, food safety inspection and large-scale agriculture. The results appear online ...

New review highlights the future of tubular solid oxide fuel cells for clean energy systems

2026-03-04

A new review published in Energy & Environment Nexus examines how innovative geometric designs of tubular solid oxide fuel cells could accelerate the transition to cleaner and more efficient energy systems. The study provides a comprehensive overview of recent advances in fabrication methods, structural designs, and real world applications of tubular SOFC technologies. Solid oxide fuel cells convert chemical energy directly into electricity with high efficiency and low emissions. They are widely considered a promising technology for addressing global energy challenges because ...

Pig farm ammonia pollution may indirectly accelerate climate warming, new study finds

2026-03-04

A new study shows that ammonia released from intensive livestock farms can significantly increase nearby soil emissions of nitrous oxide, a powerful greenhouse gas that contributes to climate change and ozone depletion. The research, published in Nitrogen Cycling, reveals that atmospheric ammonia deposition around livestock facilities can stimulate soil microbial processes that generate nitrous oxide, highlighting an overlooked pathway linking livestock pollution to global warming. Livestock farming is the largest global source of ammonia emissions. When ammonia escapes from animal housing and manure storage, it can travel through the air and deposit onto ...

Modified biochar helps compost retain nitrogen and build richer soil organic matter

2026-03-04

A new study reports that specially engineered biochar can significantly improve compost quality by reducing nitrogen loss and accelerating the formation of stable humic substances. The findings offer a promising strategy for transforming organic waste into more effective fertilizers while lowering environmental emissions. Composting plays a critical role in recycling agricultural and food wastes into nutrient rich soil amendments. However, conventional composting systems often suffer from two major challenges. Large amounts of ...

First gene regulation clinical trials for epilepsy show promising results

2026-03-04

Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and well tolerated by patients with Dravet syndrome for whom antiseizure medications are not effective. Results, published in the New England Journal of Medicine, include significant seizure reduction and improvement in other symptoms of Dravet syndrome, such as language, motor and behavior issues. Researchers also report sustained treatment benefits in ongoing open-label extension studies. “Our results are highly promising, ...

Life-changing drug identified for children with rare epilepsy

2026-03-04

A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, helping them lead much healthier and happier lives, the findings of a UCL (University College London) and Great Ormond Street Hospital-led international clinical trial show. In a new paper published in The New England Journal of Medicine, the researchers found that children with Dravet syndrome had up to 91 per cent fewer seizures while being regularly administered a new medication called zorevunersen. The results also show, for the first ...

GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: